Digitální knihovnaUPCE
 

Anti-Parkinson drug biperiden inhibits enzyme acetylcholinesterase

ČlánekOtevřený přístuppeer-reviewedpublished
Náhled

Datum publikování

2017

Vedoucí práce

Oponent

Název časopisu

Název svazku

Vydavatel

Abstrakt

Biperiden is a drug used in Parkinson disease treatment. It acts as antagonist of muscarinic receptor activated by acetylcholine. Acetylcholinesterase is an enzyme inhibited by various compounds, however there has not been proposed evidence about interaction with biperiden molecule. Therefore, we investigated this interaction using standard Ellman´s assay and experimental data were completed with in-silico prediction by SwissDock docking software. We revealed inhibition mechanism and inhibition constant was calculated to be 1.11 mmol/l; interaction of biperiden occurs in peripheral anionic subsite. Biperiden appeared to be very weak inhibitor but it can serve as a leading structure in a pharmacological research.

Rozsah stran

p. 1-5

ISSN

2314-6133

Trvalý odkaz na tento záznam

Projekt

Zdrojový dokument

Biomed Research International, volume 2017, issue: 2017

Vydavatelská verze

https://www.hindawi.com/journals/bmri/2017/2532764/

Přístup k e-verzi

open access

Název akce

ISBN

Studijní obor

Studijní program

Signatura tištěné verze

Umístění tištěné verze

Přístup k tištěné verzi

Klíčová slova

Acetylcholinesterase, biperiden, inhibitor, docking, Acetylcholinesterasa, biperiden, inhibitor, docking

Endorsement

Review

item.page.supplemented

item.page.referenced